SUBSTIPHARM
Catherine Cottenot is a highly experienced professional in the pharmaceutical industry. With a background in pharmacy and extensive experience in quality management, Catherine has held various leadership roles in companies such as SUBSTIPHARM, STALLERGENES GREER, Teva Pharmaceuticals, Cephalon, Merial, and ROCHE. Catherine's responsibilities have included managing quality teams, ensuring compliance with regulations, leading quality councils, and coordinating recalls. Catherine has a strong background in quality control, quality assurance, and pharmaceutical regulations, making their a valuable asset in the pharmaceutical industry.
SUBSTIPHARM
Substipharm is a privately held pharmaceutical Group. We develop, supply and commercialize pharmaceuticals in more than 60 countries worldwide. Our portfolio of products that we currently license out or distribute directly or through partners comprises more than 60 different molecules. Our development pipeline includes as well more than 40 ongoing projects. We have a successful portfolio of pharmaceutical products and vaccines including: Mature brands Generics Over the counter (OTC) pharmaceuticals Difficult to develop medicines Value added presentations Biological products including vaccines: